Page last updated: 2024-08-24

sparfloxacin and Pulmonary Consumption

sparfloxacin has been researched along with Pulmonary Consumption in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (26.67)18.2507
2000's10 (66.67)29.6817
2010's1 (6.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chaiprasert, A; Disratthakit, A; Doi, N; Leechawengwongs, M; Prammananan, T; Thaipisuttikul, I; Tribuddharat, C1
Khaĭmenov, AIa; Khaĭmenova, TIu; Lazareva, IaV; Sokolova, GB1
Byotra, SP; Kakar, A1
Ahluwalia, G1
Rao, S1
Mahajan, VK; Sharma, NL1
Squire, SB; Vizel, AA; Ziganshina, LE1
Biron, MG; Bogadel'nikova, IV; Borisov, SE; Khaĭmenova, TIa; Lazareva, IaV; Mozhokina, GN; Sokolova, GB; Tsibanev, AA1
Cynamon, MH; Klemens, SP; Rogge, MC; Sharpe, CA1
Grosset, J; Ji, B; Lalande, V; Paccaly-Moulin, A; Truffot-Pernot, C1
Adam, G; Haase, G; Riehl, J; Schmitt, H; Schnitzler, N; Sieberth, HG1
Erbes, R; Lode, H; Lubasch, A; Mauch, H1
Arora, VK; Gupta, R; Gupta, S; Singla, R1
Nagatake, T; Oishi, K; Satoh, S; Watanabe, K1
Kamisaka, K; Kawahara, S; Kibata, M; Konishi, H; Matsuyama, T; Mishima, Y; Shiomi, K; Tada, A; Takeuchi, M; Yoshimoto, S1

Reviews

1 review(s) available for sparfloxacin and Pulmonary Consumption

ArticleYear
Fluoroquinolones for treating tuberculosis.
    The Cochrane database of systematic reviews, 2005, Jul-20, Issue:3

    Topics: Antitubercular Agents; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Randomized Controlled Trials as Topic; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2005

Trials

3 trial(s) available for sparfloxacin and Pulmonary Consumption

ArticleYear
[Sparfloxacin in combined therapy for pulmonary tuberculosis].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2008, Volume: 53, Issue:5-6

    Topics: Adolescent; Adult; Antitubercular Agents; Arrhythmias, Cardiac; Dermatitis, Phototoxic; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Middle Aged; Mycobacterium tuberculosis; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult

2008
[The effectiveness and safety of sparfloxacine in combined therapy for tuberculosis].
    Problemy tuberkuleza i boleznei legkikh, 2007, Issue:6

    Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Middle Aged; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Pulmonary

2007
Efficacy and safety of sparfloxacin in combination with kanamycin and ethionamide in multidrug-resistant pulmonary tuberculosis patients: preliminary results.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2001, Volume: 5, Issue:6

    Topics: Adult; Anti-Infective Agents; Antitubercular Agents; Culture Media; Dermatitis, Phototoxic; Drug Therapy, Combination; Ethionamide; Fluoroquinolones; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Prospective Studies; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2001

Other Studies

11 other study(ies) available for sparfloxacin and Pulmonary Consumption

ArticleYear
Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:9

    Topics: Aminopyridines; Antitubercular Agents; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Gatifloxacin; Gene Expression; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Thailand; Tuberculosis, Pulmonary

2016
Torsade de pointes probably induced by sparfloxacin.
    The Journal of the Association of Physicians of India, 2002, Volume: 50

    Topics: Adult; Anti-Infective Agents; Antitubercular Agents; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Torsades de Pointes; Tuberculosis, Pulmonary

2002
Torsade de pointes probably induced by sparfloxain.
    The Journal of the Association of Physicians of India, 2003, Volume: 51

    Topics: Adult; Diagnosis, Differential; Female; Fluoroquinolones; Humans; India; Long QT Syndrome; Torsades de Pointes; Tuberculosis, Pulmonary

2003
Uncontrolled trial of sparfloxacin in retreatment of pulmonary tuberculosis.
    Respirology (Carlton, Vic.), 2004, Volume: 9, Issue:3

    Topics: Adult; Antitubercular Agents; Female; Fluoroquinolones; Humans; Male; Middle Aged; Retreatment; Treatment Outcome; Tuberculosis, Pulmonary

2004
Photo-onycholysis due to sparfloxacin.
    The Australasian journal of dermatology, 2005, Volume: 46, Issue:2

    Topics: Adult; Antitubercular Agents; Diagnosis, Differential; Fluoroquinolones; Humans; Male; Nails; Photosensitivity Disorders; Tuberculosis, Pulmonary

2005
Activity of levofloxacin in a murine model of tuberculosis.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:7

    Topics: Animals; Antitubercular Agents; Culture Media; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Levofloxacin; Lung; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Quinolones; Spleen; Stereoisomerism; Tuberculosis, Pulmonary

1994
Powerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in mice.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:3

    Topics: Animals; Antitubercular Agents; Colony Count, Microbial; Drug Therapy, Combination; Female; Fluoroquinolones; Lung; Mice; Mycobacterium tuberculosis; Quinolones; Spleen; Tuberculosis, Pulmonary

1993
Successful treatment of pulmonary Mycobacterium xenopi infection in a natural killer cell-deficient patient with clarithromycin, rifabutin, and sparfloxacin.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999, Volume: 29, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Fluoroquinolones; Humans; Killer Cells, Natural; Lung; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Rifabutin; Treatment Outcome; Tuberculosis, Pulmonary

1999
Sparfloxacin in the treatment of drug resistant tuberculosis or intolerance of first line therapy.
    The European respiratory journal, 2001, Volume: 17, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antitubercular Agents; Female; Fluoroquinolones; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2001
[A case report of pulmonary nocardiosis associated with bronchiectasis after pulmonary tuberculosis successfully treated with sparfloxacin].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2002, Volume: 76, Issue:3

    Topics: Anti-Infective Agents; Antitubercular Agents; Bronchiectasis; Female; Fluoroquinolones; Humans; Lung Diseases; Middle Aged; Nocardia asteroides; Nocardia Infections; Tuberculosis, Pulmonary

2002
[A case of pulmonary atypical mycobacteriosis complicated with aplastic anemia, treated with surgical resection and postoperative sparfloxacin].
    Nihon Kyobu Shikkan Gakkai zasshi, 1992, Volume: 30, Issue:7

    Topics: Anemia, Aplastic; Anti-Infective Agents; Antitubercular Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Fluoroquinolones; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Pneumonectomy; Quinolones; Tuberculosis, Pulmonary

1992